Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
J Law Med Ethics ; 46(2): 279-291, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30147005

ABSTRACT

Expanding buprenorphine access in the United States requires evidence-based decision-making that considers both the drug's potential dangers and its potential benefits. Risks associated with buprenorphine misuse and diversion highlight the need for careful, ongoing evaluation during each stage of increased access.


Subject(s)
Buprenorphine/administration & dosage , Buprenorphine/adverse effects , Narcotic Antagonists/administration & dosage , Narcotic Antagonists/adverse effects , Opiate Substitution Treatment , Opioid-Related Disorders/drug therapy , Alcohol Drinking/adverse effects , Health Policy , Health Services Accessibility , Humans , Opioid-Related Disorders/epidemiology , Prescription Drug Misuse , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...